Kyle Kline serves as Executive at GLOBUS MEDICAL INC, where they oversee executive responsibilities. Since joining the company, Kyle Kline has executed 9 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved receiving (via award) 30,000 shares valued at $0.
Kyle Kline currently holds 30,000 shares of GLOBUS MEDICAL INC (GMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Kline has been a net seller of GMED stock. They have purchased $0 and sold $2.0M worth of shares.
Kyle Kline's most recent insider trade was on Jan 21, 2026, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 8, 2026 | GMED | $363.4K | Sale | 3,594 | $101.10 | Discretionary |
| Jan 8, 2026 | GMED | $186.4K | Option Exercise | 3,594 | $51.87 | Discretionary |
| Dec 1, 2025 | GMED | $1.7M | Sale | 18,542 | $90.00 | Discretionary |
| Dec 1, 2025 | GMED | $311.8K | Option Exercise | 4,896 | $63.68 | Discretionary |
| Dec 1, 2025 | GMED | $322.2K | Option Exercise | 5,000 | $64.44 | Discretionary |
| Dec 1, 2025 | GMED | $282.1K | Option Exercise | 5,000 | $56.43 | Discretionary |
| Dec 1, 2025 | GMED | $193.7K | Option Exercise | 3,646 | $53.14 | Discretionary |